Table 3.
Characteristics of 14 patients who developed pyogenic hepatic abscess after embolization
| Variable | N (%) |
|---|---|
| First embolization | 8 (62) |
| Type of embolization | |
| Particle | 12 (86) |
| Coil | 2 (14) |
| Median time from embolization to development of abscess (days, range) |
12 (6 – 28) |
| Periprocedural antibiotics | |
| None | 2 (14) |
| Fluoroquinolone | 1 (7) |
| Clindamycin/aminoglycoside | 2 (14) |
| First generation cephalosporin | 3 (21) |
| Second generation cephalosporin | 2 (14) |
| Piperacillin/tazobactam | 4 (29) |
| Initial treatment was percutaneous drainage | 14 (100) |
| Required operative drainage | 2 (14) |
| Median hospital stay (days, range) | 2 (6 – 115) |
| ICU admission | 3 (21) |
| Deaths | 3 (21) |